NCT03310645View on ClinicalTrials.gov

Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

May 28, 2019

Study Completion Date

June 19, 2019

Conditions
Cough
Interventions
DRUG

BAY1817080

4 different doses over the course of study

DRUG

Matching Placebo

Matching placebo for BAY1817080

Trial Locations (7)

NE29 8NH

North Tyneside General Hospital, North Shields

B9 5SS

Birmingham Heartlands Hospital, Birmingham

BT9 7AB

Queen's University, Belfast

HU16 5JQ

Castle Hill Hospital, Cottingham

SE5 9RS

King's College Hospital - NHS Foundation Trust, London

M23 9LT

University Hospital of South Manchester, Manchester

M23 9QZ

Medicines Evaluation Unit, Manchester

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03310645 - Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients | Biotech Hunter | Biotech Hunter